Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Denali Therapeutics
Biotech
Denali's Hunter syndrome drug latest to be hit by FDA delay
Denali Therapeutics has become the latest on a growing list of biotechs to experience an FDA review delay in recent months.
James Waldron
Oct 14, 2025 8:09am
Denali Alzheimer's antibody clears plaques without ARIA in mice
Aug 7, 2025 2:00pm
Blocking enzyme saved mice from known Parkinson’s mechanism
Jul 2, 2025 5:26pm
Denali’s ALS drug comes up short in trial extension
Mar 6, 2025 8:20am
Denali rare disease drug clears safety study, reduces biomarkers
Feb 6, 2025 12:05pm
Tenvie takes off with $200M, assets and exec from Denali
Jan 8, 2025 8:00am
